Mark L. Berch

Array ( [id] => 4887611 [patent_doc_number] => 20080261943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'PYRROLOPYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE' [patent_app_type] => utility [patent_app_number] => 10/536119 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65612 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261943.pdf [firstpage_image] =>[orig_patent_app_number] => 10536119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317612 [patent_doc_number] => 08232389 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Method for crystallization of azetidinonecarboxylic acid' [patent_app_type] => utility [patent_app_number] => 12/308413 [patent_app_country] => US [patent_app_date] => 2007-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6187 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12308413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4486597 [patent_doc_number] => 07884100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Substituted 8-[6-amino-3-pyridyl]xanthines' [patent_app_type] => utility [patent_app_number] => 11/811823 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13357 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/884/07884100.pdf [firstpage_image] =>[orig_patent_app_number] => 11811823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279327 [patent_doc_number] => 20090131459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => '2-Thioxanthine Derivatives Acting as MPO-Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/300673 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11300 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131459.pdf [firstpage_image] =>[orig_patent_app_number] => 12300673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4470184 [patent_doc_number] => 07943625 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => '2 thioxanthine derivatives acting as MPO-inhibitors' [patent_app_type] => utility [patent_app_number] => 11/756967 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11316 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943625.pdf [firstpage_image] =>[orig_patent_app_number] => 11756967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5522038 [patent_doc_number] => 20090030019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'PURINE DERIVATIVES HAVING, IN PARTICULAR, ANTI-PROLIFERATIVE PROPERTIES, AND THEIR BIOLOGICAL USES' [patent_app_type] => utility [patent_app_number] => 11/755576 [patent_app_country] => US [patent_app_date] => 2007-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7240 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030019.pdf [firstpage_image] =>[orig_patent_app_number] => 11755576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4485763 [patent_doc_number] => 07902360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'A1 adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/754077 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13736 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902360.pdf [firstpage_image] =>[orig_patent_app_number] => 11754077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126468 [patent_doc_number] => 20070238739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process' [patent_app_type] => utility [patent_app_number] => 11/805163 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11980 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238739.pdf [firstpage_image] =>[orig_patent_app_number] => 11805163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652171 [patent_doc_number] => 20080039427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Method and compositions for treating hematological malignancies' [patent_app_type] => utility [patent_app_number] => 11/803822 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4887 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039427.pdf [firstpage_image] =>[orig_patent_app_number] => 11803822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458688 [patent_doc_number] => 20090258840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'METHOD AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES' [patent_app_type] => utility [patent_app_number] => 12/298987 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4874 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258840.pdf [firstpage_image] =>[orig_patent_app_number] => 12298987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247900 [patent_doc_number] => 20070244134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Selective antagonists of A2A adenosine receptors' [patent_app_type] => utility [patent_app_number] => 11/803312 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27577 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244134.pdf [firstpage_image] =>[orig_patent_app_number] => 11803312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 236420 [patent_doc_number] => 07595401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-29 [patent_title] => 'Therapeutic compounds and their use in cancer' [patent_app_type] => utility [patent_app_number] => 11/748362 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 132153 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/595/07595401.pdf [firstpage_image] =>[orig_patent_app_number] => 11748362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6498105 [patent_doc_number] => 20100010213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'PROCESS FOR THE CRYSTALLISATION OF CEFADROXIL' [patent_app_type] => utility [patent_app_number] => 12/300046 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2961 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010213.pdf [firstpage_image] =>[orig_patent_app_number] => 12300046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046569 [patent_doc_number] => 20070265243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Antibiotic-Bound Poly(Caprolactone) Polymer' [patent_app_type] => utility [patent_app_number] => 11/746704 [patent_app_country] => US [patent_app_date] => 2007-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2098 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265243.pdf [firstpage_image] =>[orig_patent_app_number] => 11746704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016691 [patent_doc_number] => 20070259900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'POLYMORPHS' [patent_app_type] => utility [patent_app_number] => 11/744700 [patent_app_country] => US [patent_app_date] => 2007-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3192 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259900.pdf [firstpage_image] =>[orig_patent_app_number] => 11744700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7530462 [patent_doc_number] => 07842684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'Diphenylazetidinone derivatives possessing cholesterol absorption inhibitor activity' [patent_app_type] => utility [patent_app_number] => 12/298543 [patent_app_country] => US [patent_app_date] => 2007-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20826 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842684.pdf [firstpage_image] =>[orig_patent_app_number] => 12298543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316528 [patent_doc_number] => 20090281126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Organic Compounds' [patent_app_type] => utility [patent_app_number] => 12/296714 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10756 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281126.pdf [firstpage_image] =>[orig_patent_app_number] => 12296714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285539 [patent_doc_number] => 20090099214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Organic Compounds' [patent_app_type] => utility [patent_app_number] => 12/297404 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17582 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099214.pdf [firstpage_image] =>[orig_patent_app_number] => 12297404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441994 [patent_doc_number] => 20090093633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Organic Compounds' [patent_app_type] => utility [patent_app_number] => 12/297373 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39309 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093633.pdf [firstpage_image] =>[orig_patent_app_number] => 12297373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497087 [patent_doc_number] => 20100286126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Organic Compounds' [patent_app_type] => utility [patent_app_number] => 12/297291 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58463 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286126.pdf [firstpage_image] =>[orig_patent_app_number] => 12297291 [rel_patent_id] =>[rel_patent_doc_number] =>)